| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Van Amstel Arnout Ploos last filed a Form 4 in May 2025, as Director at ZURA. Van Amstel Arnout Ploos's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 100,000 shares of ZURA. Net of sales, the ZURA filings show accumulation of 80,000 shares.
Van Amstel Arnout Ploos has 4 Form 4 filings on record from January 2024 to May 2025, all as Director at Zura Bio (ZURA), 2024–2025.
The 4 reported transactions were 3 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $496K and no sales.
The only open-market purchase was 80,000 shares of ZURA at an average $6.20 on May 17, 2024, about $496K. Twelve months later ZURA was down 82%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | ZURA Zura Bio Ltd | Director | Buy | 80,000 | $6.20 | $496,000.00 | +400.0% | -45.8% | -81.7% |